Does Augmentin (amoxicillin‑clavulanate) cause diarrhea and what is the recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin-Associated Diarrhea: Incidence and Management

Yes, Augmentin (amoxicillin-clavulanate) commonly causes diarrhea, with rates ranging from 9-26% depending on the formulation and patient age, and management focuses on hydration, probiotics, and considering alternative antibiotics if severe.

Incidence and Risk Factors

Diarrhea is the most common adverse effect of Augmentin, with the clavulanate component being the primary culprit:

  • Protocol-defined diarrhea (≥3 watery stools in one day or 2 watery stools per day for 2 consecutive days) occurs in 12.9% of pediatric patients treated with high-dose formulations 1
  • Standard formulations cause diarrhea in 9.4-11.1% of children, while older three-times-daily formulations cause rates as high as 26.7% 2
  • Young children under 2 years have significantly higher rates (18%) compared to older children (3%) 3
  • The amoxicillin-clavulanate combination specifically increases diarrhea risk with a number needed to harm of 10 (95% CI 6-17) 4

The clavulanate component, not amoxicillin alone, drives this adverse effect—amoxicillin without clavulanate does not significantly increase diarrhea risk 4.

Management Algorithm

Mild to Moderate Diarrhea (Most Cases)

Continue the antibiotic and provide supportive care:

  • Oral rehydration solution (ORS) for any dehydration—this is the cornerstone of management for mild to moderate cases 5
  • Probiotics may be offered to reduce symptom severity and duration in both adults and children with antimicrobial-associated diarrhea 5
  • Resume age-appropriate diet immediately after rehydration 5
  • Continue breastfeeding in infants throughout the episode 5

Severe or Persistent Diarrhea

Consider discontinuation if:

  • Severe dehydration develops requiring IV fluids 5
  • Bloody diarrhea or fever suggests inflammatory colitis (concern for Clostridioides difficile or pseudomembranous colitis) 1
  • Patient cannot tolerate oral intake despite antiemetics 5

Only 2.5% of patients require withdrawal due to diarrhea severity 1, so most cases can be managed supportively.

Preventive Strategies

For patients requiring Augmentin:

  • Twice-daily dosing reduces diarrhea compared to three-times-daily regimens (9.6% vs 26.7%, P<0.0001) without compromising efficacy 2
  • Lower clavulanate formulations (80 mg amoxicillin/2.85 mg clavulanate per kg/day) reduce diarrhea to 17% compared to 26% with standard dosing in young children, while maintaining clinical efficacy 6
  • Taking medication with food may reduce gastrointestinal symptoms 7

Alternative Antibiotic Consideration

For acute sinusitis specifically:

  • Amoxicillin alone (without clavulanate) shows no difference in treatment failure compared to amoxicillin-clavulanate but has lower rates of gastrointestinal symptoms (RR 1.15 for GI symptoms with clavulanate) and yeast infections (RR 1.33) 8
  • Consider switching to amoxicillin alone if diarrhea is problematic and the infection is likely susceptible to narrower-spectrum therapy

Critical Caveats

Do not use antimotility agents (loperamide) in children <18 years with acute diarrhea 5. In adults, loperamide may be used for watery diarrhea but must be avoided if there is fever or bloody stools due to risk of toxic megacolon 5.

Watch for secondary infections: Yeast infections (candidiasis) occur more frequently with amoxicillin-clavulanate (OR 7.77,95% CI 2.23-27.11) 4, and diaper dermatitis affects 21-33% of young children 6.

Pseudomembranous colitis, though rare, can occur during or after treatment and requires immediate discontinuation and C. difficile testing if suspected 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.